Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT

<div>Comparing treatment plans for a single patient. (a) The delivered HDR-SA brachytherapy isodose distribution for a scalp angiosarcoma patient. (b) The paired VMAT isodose distribution for the same patient. Magenta line denotes the PTV.</div>

Sarcoma

fig1

Figure 1

Figure 1: Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT 